XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Jul. 31, 2024
Jul. 31, 2023
Operating expenses:        
Research and development $ 11,549 $ 3,901 $ 27,042 $ 10,787
General and administrative 5,210 2,347 17,800 4,831
Total operating expenses 16,759 6,248 44,842 15,618
Loss from operations 16,759 6,248 44,842 15,618
Other (income) expense, net:        
Change in fair value of convertible debentures embedded derivative liabilities   (435)   (753)
Change in fair value of warrant liabilities   (5,521)   (3,995)
Change in fair value of convertible debentures   2,941   2,941
Interest income (3,380) (394) (7,389) (710)
Interest expense 751 1,442 2,042 3,794
Loss on extinguishment of debt     366  
Other expense, net 47 439 20 525
Total other (income) expense, net (2,582) (1,528) (4,961) 1,802
Net loss before provision for income taxes 14,177 4,720 39,881 17,420
Provision for (benefit from) income taxes (29) 0 (38) 0
Net loss and comprehensive loss 14,148 4,720 39,843 17,420
Deemed dividend attributable to redeemable convertibleb preferred shareholders   1,273   3,726
Net loss attributable to common shareholders, basic 14,148 5,993 39,843 21,146
Net loss attributable to common shareholders, diluted $ 14,148 $ 5,993 $ 39,843 $ 21,146
Net loss per share of common shares, basic $ 0.32 $ 8.55 $ 1.12 $ 30.77
Net loss per share of common shares, diluted $ 0.32 $ 8.55 $ 1.12 $ 30.77
Weighted-average common shares outstanding, basic 44,168,986 701,323 35,564,767 687,188
Weighted-average common shares outstanding, diluted 44,168,986 701,323 35,564,767 687,188